| MolName | (5Z)-5-[[4-oxo-2-(oxolan-2-ylmethylamino)pyrido[1,2-a]pyrimidin-3-yl]methylidene]-3-(3-phenylpropyl)-2-sulfanylidene-1,3-thiazolidin-4-one |
| MolecularFormula | C26H26N4O3S2 |
| Smiles | O=C(/C(/S1)=C/C2=C(NCC3OCCC3)N=C(C=CC=C3)N3C2=O)N(CCCc2ccccc2)C1=S |
| InChI | InChI=1S/C26H26N4O3S2/c31-24-20(23(27-17-19-11-7-15-33-19)28-22-12-4-5-13-29(22)24)16-21-25(32)30(26(34)35-21)14-6-10-18-8-2-1-3-9-18/h1-5,8-9,12-13,16,19,27H,6-7,10-11,14-15,17H2/t19-/m1/s1 |
| InChIK | HMXMTTCZJKRXIG-LJQANCHMSA-N |
| TotalMolweight | 506.649 |
| Molweight | 506.649 |
| MonoisotopicMass | 506.144631 |
| CLogP | 1.8672 |
| CLogS | -5.842 |
| H Acceptors | 7 |
| H Donors | 1 |
| TotalSurfaceArea | 379.44 |
| Relative PSA | 0.29422 |
| PolarSurfaceArea | 131.63 |
| Druglikeness | 4.5719 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | polar activated DB |
| Shape Index | 0.51429 |
| Fragments | 1 |
| Non HAtoms | 35 |
| NonCHAtoms | 9 |
| Electronegative Atoms | 9 |
| StereoCenters | 1 |
| Rotatable Bond | 8 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 1 |
| Aromatic Atoms | 6 |
| Sp3Atoms | 11 |
| Symmetricatoms | 2 |
| Amides | 2 |
| BasicNitrogens | 1 |
| StereoCon | racemate |
Click to Load Molecule:
1 - (5Z)-5-[[4-oxo-2-(oxolan-2-ylmethylamino)pyrido[1,2-a]pyrimidin-3-yl]methylidene]-3-(3-phenylpropyl)-2-sulfanylidene-1,3-thiazolidin-4-one | 2 - (5Z)-5-[[4-oxo-2-(oxolan-2-ylmethylamino)pyrido[1,2-a]pyrimidin-3-yl]methylidene]-3-(3-phenylpropyl)-2-sulfanylidene-1,3-thiazolidin-4-one